1999 Richard J. Duma/NFID Annual Press Conference and Symposium on Infectious Diseases
Thursday, April 22, 1999
The National Press Club, First Amendment Room
529 14th Street, NW, Washington, D.C.
Agenda
10:00 a.m.
About the National Foundation for Infectious Diseases (NFID) and the Richard J. Duma/NFID Annual Press Conference and Symposium on Infectious Diseases
William J. Martone, M.D.
Senior Executive Director
National Foundation For Infectious Diseases
Bethesda, MD
10:05 a.m.
Why You Should Know About Hepatitis C
Leslye D. Johnson, Ph.D.
Chief, Enteric Diseases Branch
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Bethesda, Maryland
10:25 a.m.
Restoring the Public Trust in Vaccinations: A New IDSA Initiative
Bruce G. Gellin, M.D., M.P.H.
Vaccine Initiative Steering Committee
Infectious Diseases Society of America
Nashville, Tennessee
10:45 a.m.
Tuberculosis in the New Millennium: Why We Need to Keep Up Our Guard
Introductory Comments
Ralph Nader
Founder
Princeton Project 55 Inc.
Washington, D.C.
Presentation
Kenneth Castro, M.D.
Director, Division of Tuberculosis
Center for AIDS, TB, and STD
Centers for Disease Control and Prevention
Atlanta, Georgia
11:05 a.m.
Whatever Happened to Herpes? The Forgotten Epidemic
Gray Davis, Ph.D.
Sexual Health Communications
Durham, North Carolina
11:25 a.m.
The Role of Chlamydia in Atherosclerosis
J. Thomas Grayston, M.D.
University of Washington
Seattle, Washington
11:45 a.m.
Panel Discussion
Moderator--Richard J. Duma, M.D., Ph.D.
Member, NFID Board of Trustees
Director, Infectious Diseases
Halifax Medical Center
Daytona Beach, Florida
Each panelist will be asked for his/her prediction about breaking infectious disease news for 2000, followed by questions from the audience.
12:00 p.m.
Adjournment/Complimentary Lunch
Presented by:
The National Foundation for Infectious Diseases
with the support of unrestricted educational grants from:
Bayer Corporation, Pharmaceutical Division
Aviron
Glaxo Wellcome, Inc.
Merck & Co., Inc.
Pfizer Inc.
Pharmacia & Upjohn, Inc.
Roche Laboratories
Zeneca Pharmaceuticals
